Label: GUAIFENESIN AND DEXTROMETHORPHAN HBR tablet, extended release

  • NDC Code(s): 11673-267-05, 11673-267-57, 11673-267-60
  • Packager: Target Corporation
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated July 8, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredients

    (in each extended-release tablet)
    Dextromethorphan Hydrobromide USP 60 mg
    Guaifenesin USP 1200 mg

  • Purpose

    Cough suppressant
    Expectorant

  • Uses


    • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
    • temporarily relieves:
      • cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants
      • the intensity of coughing
      • the impulse to cough to help you get to sleep
  • Warnings


    Do not use

    • for children under 12 years of age
    • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
  • Ask a doctor before use if you have


    • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
    • cough accompanied by too much phlegm (mucus)
  • When using this product


    • do not use more than directed
  • Stop use and ask a doctor if


    • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
  • If pregnant or breast-feeding,


    ask a health professional before use.

  • Keep out of reach of children.


    In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • Directions


    • do not crush, chew, or break tablet
    • take with a full glass of water
    • this product can be administered without regard for timing of meals
    • adults and children 12 years and older: 1 tablet every 12 hours; not more than 2 tablets in 24 hours
    • children under 12 years of age: do not use
  • Other information


    • store at 20° to 25°C (68° to 77°F)
  • Inactive ingredients


    colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch (maize)

  • Questions?


    call 1-855-274-4122  You may also report side effects to this phone number.

    Distributed by Target Corporation

    Minneapolis, MN 55403

    Made in India

    TM & ©2024 Target Brands, Inc.

  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg/60 mg (14 Tablet Bottle)

    Maximum Strength

    Mucus
    Relief DM
    Guaifenesin and Dextromethorphan
    HBr     Extended-release Tablets
    1200 mg/60 mg
    Expectorant and Cough Suppressant
    •    Controls cough
    •    Thins and loosens mucus

    up&up™

    12
    Hour
    14 EXTENDED-RELEASE TABLETS


    PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg/60 mg (14 Tablet Bottle)

  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg/60 mg (14 Tablet Carton Label)

    Compare to the active ingredients of
    Maximum Strength Mucinex® DM*

    Maximum Strength

    NDC 11673-267-05

    Mucus
    Relief DM
    Guaifenesin and Dextromethorphan
    HBr     Extended-release Tablets
    1200 mg/60 mg
    Expectorant and Cough Suppressant
    •    Controls cough
    •    Thins and loosens mucus

    up&up™

    12
    Hour

    Actual Size
    14 Tablets

    14 EXTENDED-RELEASE TABLETS


    PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg/60 mg (14 Tablet Carton Label)
     

  • INGREDIENTS AND APPEARANCE
    GUAIFENESIN AND DEXTROMETHORPHAN HBR 
    guaifenesin and dextromethorphan hbr tablet, extended release
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11673-267
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN1200 mg
    DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH) (DEXTROMETHORPHAN - UNII:7355X3ROTS) DEXTROMETHORPHAN HYDROBROMIDE60 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    POVIDONE K90 (UNII: RDH86HJV5Z)  
    POVIDONE K25 (UNII: K0KQV10C35)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    Product Characteristics
    ColorWHITE (white to off-white) Scoreno score
    ShapeOVALSize22mm
    FlavorImprint Code X;63
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:11673-267-051 in 1 CARTON07/04/2024
    114 in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:11673-267-571 in 1 CARTON07/04/2024
    228 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:11673-267-601 in 1 CARTON07/04/2024
    342 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20694107/04/2024
    Labeler - Target Corporation (006961700)
    Registrant - Aurohealth LLC (078728447)
    Establishment
    NameAddressID/FEIBusiness Operations
    Aurobindo Pharma Limited650381903ANALYSIS(11673-267) , MANUFACTURE(11673-267)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!